Skip to main content
. 2014 Jul 22;44(8):743–752. doi: 10.1111/eci.12291

Figure 3.

Figure 3

Boxplots of plasma (open boxes) and serum (stippled boxes) concentrations at 12 h following administration of 5 mg apixaban bid at months 3–6 in patients with atrial fibrillation or prevention of recurrent venous thromboembolism. Concentrations were measured using different chromogenic substrate assays.